A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey

被引:54
|
作者
Ozgoztasi, O [1 ]
Baydar, I [1 ]
机构
[1] GAZIANTEP UNIV,DEPT DERMATOL & INFECT DIS,GAZIANTEP,TURKEY
关键词
D O I
10.1046/j.1365-4362.1997.00022.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
An open-labeled, randomized clinical trial to evaluate the efficacy of paromomycin ointment as compared with ketoconazole was conducted on seventy-two patients of both sexes and different ages with the confirmed diagnosis of cutaneous leishmaniasis (CL). All patients had a complete clinical evaluation for other diseases. Patients were excluded if they were pregnant or nursing or if they had serious concomitant diseases. Patients were divided randomly into two treatment groups: in the first group 40 patients were treated with an ointment containing 15% paromomycin sulfate and 12% methylbenzothonium chloride in white soft paraffin (labeled as p-ointment by El-On(1)) twice daily for 15 days. Treated lesions were left uncovered. The second group consisted of 32 patients who received ketoconazole 400 mg/day orally for 30 days. This dosage was reduced to 200 mg/day for patients below 12 years of age. In all cases the diagnosis was based on positive smear and/or culture. Direct smears were prepared from the exudate obtained by a small incision made at the edge of the lesion with a sterile surgical blade or lancet and stained using the Giemsa method for leishmania bodies (Pig. 1). In smear negative and suspected cases aspirates taken by puncturing the lesions were inoculated onto NNN (Novy, McNeal, Nicolle) medium for culture. The cultures were incubated at 28 degrees C and the development of motile promastigotes was observed. Clinical and parasitological evaluations of the patients were performed at the end of the treatment period and 4 weeks post-treatment. A cure was defined as complete healing and disappearance of the lesion or reversible hypopigmentation at the site of lesion. Incomplete or partial improvement was defined as a reduction in the size of a lesion and the absence of parasites on smear or culture. A treatment failure was defined as the absence of any changes in the lesion and persistence of parasites on smear or culture.
引用
下载
收藏
页码:61 / 63
页数:3
相关论文
共 50 条
  • [41] In vitro skin permeation and retention of paromomycin from liposomes for topical treatment of the cutaneous leishmaniasis
    Ferreira, LS
    Ramaldes, GA
    Nunan, EA
    Ferreira, LAM
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2004, 30 (03) : 289 - 296
  • [42] Pharmacokinetics and Absorption of Paromomycin and Gentamicin from Topical Creams Used To Treat Cutaneous Leishmaniasis
    Ravis, William R.
    Llanos-Cuentas, Alejandro
    Sosa, Nestor
    Kreishman-Deitrick, Mara
    Kopydlowski, Karen M.
    Nielsen, Carl
    Smith, Kirsten S.
    Smith, Philip L.
    Ransom, Janet H.
    Lin, Yuh-Jing
    Groglf, Max
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (10) : 4809 - 4815
  • [43] Comparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial
    Farajzadeh, Saeedeh
    Esfandiarpour, Iraj
    Haghdoost, Ali Akbar
    Mohammadi, Saman
    Mohebbi, Azadeh
    Mohebbi, Elham
    Mostafavi, Mahshid
    IRANIAN JOURNAL OF PARASITOLOGY, 2015, 10 (01) : 1 - 8
  • [44] Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran
    Iraji, F
    Sadeghinia, A
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2005, 99 (01): : 3 - 9
  • [45] Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial
    Rajaraman, Revathi
    Bhat, Parameshwar
    Vaidee, Vikram
    Maskibail, Sowmyalatha
    Raghavan, Anita
    Sivasubramaniam, Siddharthan
    Namperumalsamy, Venkatesh Prajna
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2015, 4 (03): : 146 - 150
  • [46] Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis: A Randomized Controlled Trial
    Ravuri, Sasya
    Mittal, Rashmi
    Bagga, Bhupesh
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2015, 4 (06): : 399 - 399
  • [47] TOPICAL THERAPY OF CUTANEOUS LEISHMANIASIS WITH 2-PERCENT KETOCONAZOLE OINTMENT AND DMSO
    DUTZ, W
    AGARVAL, N
    BASHARDOST, MZ
    BENTLEY, G
    KINDMARK, CO
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1987, 26 (03) : 199 - 199
  • [48] Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran
    Asilian, A
    Jayaler, T
    Nilforooshzadeh, M
    Ghassemi, RL
    Peto, R
    Wayling, S
    Olliaro, P
    Modabber, F
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2003, 81 (05) : 353 - 359
  • [49] A RANDOMIZED, DOUBLE-BLIND, CLINICAL-TRIAL OF TOPICAL CLOTRIMAZOLE VERSUS MICONAZOLE FOR TREATMENT OF CUTANEOUS LEISHMANIASIS IN THE EASTERN PROVINCE OF SAUDI-ARABIA
    LARBI, EB
    ALKHAWAJAH, A
    ALGINDAN, Y
    JAIN, S
    ABAHUSAIN, A
    ALZAYER, A
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1995, 52 (02): : 166 - 168
  • [50] ABLATIVE FRACTIONAL LASER RESURFACING WITH TOPICAL PAROMOMYCIN AS ADJUNCTIVE TREATMENT FOR A RECALCITRANT CUTANEOUS LEISHMANIASIS WOUND
    Basnett, Andrew
    Tuyet Nguyen
    Cannavino, Christopher
    Krakowski, Andrew
    LASERS IN SURGERY AND MEDICINE, 2016, 48 : 31 - 31